Bergmeijer, Thomas O <br/><br/>
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).  [electronic resource] 

 -  American heart journal  04 2018 
 - 152-159 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2017.12.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Acute Coronary Syndrome--diagnosis<br/>Clopidogrel--therapeutic use<br/>Genetic Association Studies<br/>Genome-Wide Association Study<br/>Internationality<br/>Molecular Targeted Therapy--methods<br/>Pharmacogenetics<br/>Prognosis<br/>Receptors, Purinergic P2Y12--drug effects<br/>Risk Assessment<br/>Survival Rate<br/>Treatment Outcome